Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia (HI/HA) Syndrome

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

1 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Our team is working on a study to see if children with HI/HA Syndrome tolerate Vitamin E supplementation. This is an experimental, non-FDA approved use of Vitamin E which will lead to further studies to evaluate if Vitamin E can be used as a treatment for HI/HA. The study involves taking Vitamin E once a day for two weeks at home, completing a tolerability questionnaires, and two, one-day visits to the CHOP outpatient Center for Human Phenomic Science (one visit before and one visit after taking the Vitamin E supplement for two weeks). During each study visit, fasting oral protein tolerance will be performed and blood samples will be drawn. If you're interested in learning more, please contact us at rosenfelde@chop.edu.

Eligibility & Criteria

IRB #:
17-014550
Official Title:
Vitamin E Supplementation in Hyperinsulinism/Hyperammonemia Syndrome
Study Phase:
Pilot
Eligible Age Range:
1 - 40 Years
Gender:
All
Study Categories: